AviadoBio Ltd.
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://aviadobio.com
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Phase 1
Recruiting
- Conditions
- FTDFrontotemporal DementiaFTD-GRNDementia, Frontotemporal
- Interventions
- Procedure: Intrathalamic AAV.PGRN administrationGenetic: Intrathalamic AVB-101
- First Posted Date
- 2023-10-03
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- AviadoBio Ltd
- Target Recruit Count
- 9
- Registration Number
- NCT06064890
- Locations
- π΅π±
Euromedis Sp. z o.o., Szczecin, Poland
π΅π±Centrum Medyczne NeuroProtect Sp z o.o., Warsaw, Poland
π΅π±Mazowiecki Szpital Brodnowski Sp. z o. o., Warsaw, Poland
Β© Copyright 2025. All Rights Reserved by MedPath